Wockhardt’s heartburn drug in US recalled

Press Trust of India New Delhi | Updated on January 24, 2018

The US-based pharma company Allegiant Health is recalling over 85,000 cartons of heartburn relief tablets in the US made by Wockhardt in India.

This voluntary recall is attributed to purported failure of the Indian drug maker to adequately investigate customer complaints.

According to the Enforcement Report for the week of June 24, 2015, the US health regulator has said 86,106 cartons of OTC Famotidine tablets USP of 20 mg are being voluntarily recalled by Allegiant Health.

“The Class II ongoing recall is initiated and the reason for recall is CGMP deviations: failure of the manufacturer, Wockhardt Ltd, to adequately investigate customer complaints,” the US Food and Drug Administration (USFDA) said in the report.

Published on June 29, 2015

Follow us on Telegram, Facebook, Twitter, Instagram, YouTube and Linkedin. You can also download our Android App or IOS App.

This article is closed for comments.
Please Email the Editor